Skip to main content
Signal8

CRESCENT BIOPHARMA, INC. (CBIO)

Crescent Biopharma, Inc. is a biotechnology firm dedicated to the research and development of novel cancer therapies. Its investigational portfolio notably includes CR-001, a proprietary bispecific antibody engineered to simultaneously target PD-1 and VEGF pathways for the treatment of solid tumors. The company's pipeline further comprises CR-002 and CR-003. Crescent Biopharma also maintains a strategic alliance with Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., focusing on the joint advancement and commercialization of oncology therapeutics, encompassing innovative combination approaches. The company's operations are headquartered in Waltham, Massachusetts.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Crescent Biopharma, Inc. logo

Crescent Biopharma, Inc.

NASDAQ:CBIOHealthcare
-4.19%$13.48
AH$13.67+1.41%vs close
Mkt Cap$500.74M
Float20.86M
O/S37.15M
Vol
$ Vol
RVOL
Inst Own79.5%
SI21.2%
Earnings
Dilution
Financials Summary
Revenue$10.84M
Net Income-$153.94M
Total Assets$240.29M
Free Cash Flow-$144.45M
Debt & Equity
Debt 1%
Equity 97%
Preferred 2%
Total Debt$1.64M
Total Equity$203.01M
Preferred Stock$4M
Shares Outstanding
Short Interest
Split History2 splits · 2 reverse
  1. 1:15Reverse split
    Oct 31, 202315 shares → 1
  2. 1:15Reverse split
    Feb 6, 200615 shares → 1
Balance Sheet Details
Assets$240.29M
Liabilities$37.28M
Accounts Receivable$18M
Accounts Payable$10M
Inventory$0
PP&E (Net)$2.31M
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
Revenue$10.84M$0$10K$75K$1.16M$10.16M$0$0$0$19K$20.07M$15.03M$3.99M$15.26M$3.81M
YoY Growth---86.7%-93.5%-88.6%-----99.9%33.6%276.4%-73.8%300.0%-
Cost of Revenue$0$0$0$0$0$0$899K$275K$264K$0$0$0$0$0$0
Gross Profit$10.84M$0$10K$75K$1.16M$10.16M-$899K-$275K-$264K$0$20.07M$15.03M$3.99M$15.26M$0
Gross Margin100.0%-100.0%100.0%100.0%100.0%----100.0%100.0%100.0%100.0%-
Research and Development$138.09M$28.06M$20.07M$28.39M$47.49M$44.93M$47.03M$40.09M$24.1M$23.28M$25.05M$19.57M$11.7M$9.44M$7.8M
Selling, General, and Administrative$25.39M$16.32M$19.21M$19.09M$17.12M$16.74M$14.36M$11.41M$9.83M$8.65M$7.81M$6.6M$2.9M$2.18M$2.1M
Other$0$5.51M$637$443$0$0$0$0-$264K$0$0-$262-$1K-$78$0
Total Operating Expenses$163.48M$49.9M$39.29M$47.48M$64.61M$61.67M$61.39M$51.51M$33.67M$31.93M$32.86M$26.17M$14.6M$11.62M$9.9M
Operating Income (EBIT)-$152.63M-$49.9M-$39.28M-$47.4M-$63.45M-$51.51M-$61.39M-$51.51M-$33.93M-$31.91M-$12.78M-$11.14M-$10.61M$3.64M-$6.08M
Operating Margin-1407.5%--392752.9%-63204.4%-5470.7%-506.8%----172505.3%-63.7%-74.1%-265.7%23.8%-159.5%
Interest Expense$2.19M$852K$0$0$0$0$0$0$0$0$0$0$0$0$0
Interest Income$2.88M$1M$2.38M$715K$20K$482K$3.5M$3.23M$651K$104K$0$0$0$0$0
Other Income (Expense)$690K$1.37M$2.38M$715K$20K$482K$3.5M$3.23M$651K$104K$15K$18K-$132$21K-$28K
Income Before Tax (EBT)-$151.94M-$48.52M-$36.9M-$46.69M-$63.43M-$51.03M-$57.89M-$48.27M-$33.28M-$31.81M-$12.77M-$11.12M-$10.61M$3.66M-$6.11M
Income Tax Expense$2M$0$0$0$0$0-$3.78M$3.23M$0$0$0$0$0$0$0
Net Income-$153.94M-$48.52M-$36.9M-$46.69M-$63.43M-$51.03M-$54.12M-$48.27M-$33.28M-$31.81M-$12.77M-$11.12M-$10.61M$3.66M-$6.11M
Net Income Margin-1419.6%--368994.2%-62251.7%-5469.0%-502.1%----171945.1%-63.6%-74.0%-265.6%24.0%-160.3%
Supplementary Data
EPS-14.78-63.22-58.25-88.88-123.27-111.60-133.84-117.61-113.22-149.65-67.17-60.27-199.32305.64-32.55
Diluted EPS-14.78-63.22-58.25-88.88-123.27-111.60-133.84-117.61-113.22-149.65-67.17-60.27-199.32305.64-32.55
Weighted Average OS10.41M767,580633,424525,311514,532457,211432,547410,446293,957212,563190,105184,52253,20911,962187,819
EBITDA-$149.67M-$44.17M-$39.12M-$47.2M-$63.18M-$51.24M-$56.99M-$51.23M-$33.67M-$31.72M-$12.59M-$10.98M-$10.47M$3.73M-$6M
EBITDA Margin-1380.2%--391213.5%-62927.6%-5447.9%-504.2%----171475.4%-62.7%-73.1%-262.3%24.5%-157.3%
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
Assets
Current Assets
Cash and Cash Equivalents$213.19M$34.77M$41.79M$47.87M$90.25M$137.04M$158.2M$209.92M$123.92M$40.04M$46.8M$55.2M$2.31M$17.37M$28.17M
Short-Term Investments$0$0$0$0$0$0$0$0$0$11K$9K$16K$1K$17.37M$28.17M
Cash and Short-Term Investments$213.19M$34.77M$41.79M$47.87M$90.25M$137.04M$158.2M$209.92M$123.92M$40.04M$46.8M$55.2M$2.31M$17.37M$28.17M
Accounts Receivable$18M$0$176K$144K$1K$2K$186K$413K$102K$269K$39K$22K$95K$0$0
Inventory$0$0$0$0$0$0$0-$405$0$199K$0-$77$0$0$0
Other Current Assets$1.28M$38K$0$0$0$0$0$0$0-$199K$9K$58K$2.31M$0$0
Total Current Assets$236.66M$34.8M$43.79M$50.71M$90.79M$138.27M$162.53M$212.27M$127.22M$40.52M$47.24M$56.12M$4.88M$17.97M$28.37M
Long-Term Assets
Property, Plant & Equipment Net$2.31M$0$768K$751K$1.95M$2.95M$3.83M$957K$1.11M$1.06M$521K$452K$400K$451K$235K
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$1.32M$813K$758K$345K$1.61M$1.61M$1.61M$1.61M$257K$812K$697K$697K$0$0$309K
Total Long-Term Assets$3.64M$813K$1.53M$1.1M$3.56M$4.56M$5.44M$2.57M$1.36M$1.87M$1.22M$1.15M$400K$451K$543K
Other Assets$0$0$0$0$0$0$0-$272$0-$327-$279$27$0$0$0
Total Assets$240.29M$35.62M$45.32M$51.81M$94.35M$142.83M$167.97M$214.84M$128.58M$42.39M$48.46M$57.26M$5.28M$18.42M$28.91M
Liabilities
Current Liabilities
Accounts Payable$10M$107K$868K$970K$2.11M$2.09M$1.44M$2.66M$2.65M$1.57M$564K$874K$1.14M$764K$536K
Short-Term Debt$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Current Income Tax Payable$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$4.16M$0$0$0$0$0$0$0$0$69K$0$0$0$3.99M$15M
Other Current Liabilities$10.12M$76K$2.96M$2.97M$2.5M$3.91M$3.03M$99K$78K$0$0$97K$104K$92K$635K
Total Current Liabilities$36.07M$9.61M$6.84M$8.88M$11.82M$12.43M$10.95M$8.76M$8.17M$6.33M$7.75M$6.46M$2.28M$5.69M$16.41M
Long-Term Liabilities
Long-Term Debt$0$37.48M$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0$0$97K$200K$4.04M
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$0$4M$0$0$0$264K$0$612K$707K$754K$244K$0$97K$0$0
Total Long-Term Liabilities$1.21M$41.48M$67K$0$919K$2.18M$2.82M$612K$707K$754K$244K$0$97K$200K$4.04M
Other Liabilities$0$0$0$0$0$0$0$223$0-$196-$625$0$0$0$0
Total Liabilities$37.28M$51.1M$6.9M$8.88M$12.74M$14.61M$13.77M$9.38M$8.88M$7.09M$7.99M$6.46M$2.38M$5.89M$20.45M
Stockholders' Equity
Preferred Stock$4M$0$0$0$0$0$0$0$0$0$346$0$31K$31K$31K
Common Stock$28K$1K$64K$54K$52K$49K$43K$43K$34K$23K$19K$19K$1K$930$930
Retained Earnings-$171.81M-$17.87M-$456.49M-$419.59M-$372.9M-$309.47M-$258.44M-$200.55M-$152.28M-$118.98M-$87.17M-$74.4M-$63.28M-$52.67M-$56.33M
Comprehensive Income & Other$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Stockholders' Equity$374.79M$2.39M$494.84M$462.46M$454.45M$437.64M$412.6M$405.97M$271.94M$154.25M$127.62M$125.18M$66.18M$65.2M$64.78M
Total Equity$203.01M-$15.48M$38.41M$42.93M$81.6M$128.22M$154.2M$205.46M$119.7M$35.3M$40.47M$50.8M$2.91M$12.53M$8.46M
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$240.29M$35.62M$45.32M$51.81M$94.35M$142.83M$167.97M$214.84M$128.58M$42.39M$48.46M$57.26M$5.28M$18.42M$28.91M
Supplementary Data
Total Debt$1.64M$37.48M$808K$919K$1.92M$2.82M$3.62M$0$0$0$0$0$0$0$0
Net Debt-$211.55M$2.72M-$40.98M-$46.95M-$88.33M-$134.22M-$154.58M-$209.92M-$123.92M-$40.04M-$46.8M-$55.2M-$2.31M-$17.37M-$28.17M
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-31
Operating Activities
Net Income-$153.94M-$37.88M-$36.9M-$46.69M-$63.43M-$51.03M-$57.89M-$48.27M-$33.28M-$31.81M-$12.77M-$11.12M-$10.61M$3.66M-$6.11M
Depreciation & Amortization$84K$35K$153K$207K$265K$271K$899K$275K$264K$191K$191K$159K$133K$100K$84K
Deferred Income Tax$0$0$0$0$0$0$0$0$0-$2.96M-$2.32M$0-$426K-$415K$0
Stock-Based Compensation$13.3M$4.77M$3.56M$3.86M$6.09M$6.9M$6.22M$4.59M$3.76M$2.96M$2.32M$1.64M$426K$415K$376K
Changes in Working Capital:
  Accounts Receivable-$18M$0$0$0$0$0$0$0$0$0$0$0$187K$0$0
  Inventory$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
  Accounts Payable$2.08M-$539K-$102K-$1.14M$18K$654K-$1.23M$16K$1.06M$1M-$310K-$271K$381K$229K$83K
  Other Working Capital$2.55M$1.7M-$2.46M-$3.52M-$1.18M$3.28M$21K$64K-$1.57M-$2.08M$2.31M$5.32M-$6.06M-$14.87M$19.42M
Total Working Capital Change-$13.37M$1.16M-$2.56M-$4.66M-$1.17M$3.93M-$1.21M$80K-$512K-$1.08M$2M$5.04M-$5.49M-$14.64M$19.51M
Other Non-Cash Items$82.4M$814K$865K$829K$751K$681K$0$168$0$2.96M$2.32M$1K$426K$415K$0
Net Cash from Operating-$71.53M-$31.1M-$34.88M-$46.46M-$57.49M-$39.24M-$51.98M-$43.33M-$29.77M-$29.73M-$8.24M-$4.28M-$15.54M-$10.47M$13.85M
Investing Activities
Capital Expenditures-$919K-$10K-$21K-$84K-$15K-$69K-$145K-$126K-$294K-$704K-$269K-$213K-$82K-$316K-$182K
Acquisitions$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Purchases of Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Sales of Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Investing Activities-$72M$30K$0$0$0$0$0$0$0$0$0$0$0-$10K-$58K
Net Cash from Investing-$72.92M$20K-$21K-$84K-$15K-$69K-$145K-$126K-$294K-$704K-$269K-$213K-$82K-$326K-$240K
Financing Activities
Debt Repaid--------------$24K
Common Stock Issuance$321.89M$0$28.71M$4.16M$10.7M$17.82M$413K$128.43M$113.57M$23.6M$114K$57.25M$559K$237$3
Common Stock Repurchases-$177K$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities$1.27M$5K$116K$0$25K$319K$0$1.02M$373K$73K$0$134K$0$0$0
Net Cash from Financing$322.98M$5K$28.82M$4.16M$10.72M$18.14M$413K$129.45M$113.95M$23.67M$114K$57.38M$559K$237-$24K
Forex Effect$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Net Change in Cash$178.53M-$31.07M-$6.08M-$42.38M-$46.78M-$21.17M-$51.72M$85.99M$83.88M-$6.76M-$8.4M$52.89M-$15.06M-$10.8M$13.59M
Supplementary Data
Operating Cash Flow-$71.53M-$31.1M-$34.88M-$46.46M-$57.49M-$39.24M-$51.98M-$43.33M-$29.77M-$29.73M-$8.24M-$4.28M-$15.54M-$10.47M$13.85M
Capital Expenditure-$72.92M-$10K-$21K-$84K-$15K-$69K-$145K-$126K-$294K-$704K-$269K-$213K-$82K-$316K-$182K
Free Cash Flow-$144.45M-$31.11M-$34.9M-$46.54M-$57.5M-$39.31M-$52.13M-$43.46M-$30.06M-$30.44M-$8.51M-$4.49M-$15.62M-$10.79M$13.67M
Cash at Beginning$34.77M$41.79M$47.87M$90.25M$137.04M$158.2M$209.92M$123.92M$40.04M$46.8M$55.2M$2.31M$17.37M$28.17M$14.58M
Cash at End$213.3M$10.72M$41.79M$47.87M$90.25M$137.04M$158.2M$209.92M$123.92M$40.04M$46.8M$55.2M$2.31M$17.37M$28.17M